The Guilak and Gersbach Labs receive an R21 grant from the National Institutes of Health to study the role of genetic variation in osteoarthritis.

The Guilak and Gersbach Labs receive an R21 grant from the National Institutes of Health to study the role of genetic variation in osteoarthritis.